NCT04853537

Brief Summary

This randomized controlled clinical trial will assess the impact of intermittent fasting on the incidence of gestational DM in obese pregnant women in 3rd trimester and its effect on maternal and neonatal outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
252

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 21, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

July 20, 2021

Status Verified

April 1, 2021

Enrollment Period

3 months

First QC Date

April 13, 2021

Last Update Submit

July 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • gestational diabetes

    percentage of diabetes in obese patient is increased by 1.3% and it will be assessed by glucose tolerance test

    from 24-36 weeks of gestation

Secondary Outcomes (6)

  • Maternal weight gain,

    from 24-36 weeks of gestation

  • Fetal weight

    on labour

  • fetal Apgar score

    on labour

  • NICU(neonatal intensive care unit) admission

    on labour

  • mode of delivery

    on 36 weeks of gestation

  • +1 more secondary outcomes

Study Arms (2)

study group

EXPERIMENTAL

• 126 women will fast 16 consecutive hours per day including sleeping hours. and follow them from 26w till 36w by GTT(glucose tolerance test) and the weight gain and incidence of gestational diabetes

Dietary Supplement: intermittent fasting diet

control group

NO INTERVENTION

• 126 women will not fasting with the same life style and follow the incidence of gestational diabetes

Interventions

intermittent fasting dietDIETARY_SUPPLEMENT

intermittent fasting diet to obese pregnant women \>30 BMI and incidence of gestational diabetes

study group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- 1. Healthy pregnant women. 2. Age (18 - 35 years old). 3. Women with BMI (\_\> 30 kg/m2).
  • \. A living singleton pregnancy. Gestational age (24- 27 weeks).(recruitment time)

You may not qualify if:

  • \- 1. Multiple gestations. 2. Women with diabetes 3. pre-pregnancy cardiovascular disease, chronic hypertensive, and pregnancy-induced hypertension; blood pressure \_\> 140/90.
  • \. Women with hepatic, renal diseases or coagulopathy 5. Women with peptic ulcer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Alkandari JR, Maughan RJ, Roky R, Aziz AR, Karli U. The implications of Ramadan fasting for human health and well-being. J Sports Sci. 2012;30 Suppl 1:S9-19. doi: 10.1080/02640414.2012.698298. Epub 2012 Jun 29.

    PMID: 22742901BACKGROUND
  • Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial. JAMA Netw Open. 2018 Jul 6;1(3):e180756. doi: 10.1001/jamanetworkopen.2018.0756.

    PMID: 30646030BACKGROUND
  • Corley BT, Carroll RW, Hall RM, Weatherall M, Parry-Strong A, Krebs JD. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med. 2018 May;35(5):588-594. doi: 10.1111/dme.13595. Epub 2018 Feb 27.

    PMID: 29405359BACKGROUND
  • Furmli S, Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep. 2018 Oct 9;2018:bcr2017221854. doi: 10.1136/bcr-2017-221854.

    PMID: 30301822BACKGROUND
  • Grajower MM, Horne BD. Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus. Nutrients. 2019 Apr 18;11(4):873. doi: 10.3390/nu11040873.

    PMID: 31003482BACKGROUND
  • Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010 Jun;100(6):1047-52. doi: 10.2105/AJPH.2009.172890. Epub 2010 Apr 15.

    PMID: 20395581BACKGROUND
  • Harris L, Hamilton S, Azevedo LB, Olajide J, De Brun C, Waller G, Whittaker V, Sharp T, Lean M, Hankey C, Ells L. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep. 2018 Feb;16(2):507-547. doi: 10.11124/JBISRIR-2016-003248.

    PMID: 29419624BACKGROUND
  • Klempel MC, Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J. 2012 Nov 21;11:98. doi: 10.1186/1475-2891-11-98.

    PMID: 23171320BACKGROUND
  • Sakar MN, Gultekin H, Demir B, Bakir VL, Balsak D, Vuruskan E, Acar H, Yucel O, Yayla M. Ramadan fasting and pregnancy: implications for fetal development in summer season. J Perinat Med. 2015 May;43(3):319-23. doi: 10.1515/jpm-2013-0289.

    PMID: 24810552BACKGROUND
  • Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, Groshen S, Mack WJ, Guen E, Di Biase S, Cohen P, Morgan TE, Dorff T, Hong K, Michalsen A, Laviano A, Longo VD. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017 Feb 15;9(377):eaai8700. doi: 10.1126/scitranslmed.aai8700.

    PMID: 28202779BACKGROUND

MeSH Terms

Conditions

Intermittent FastingDiabetes, GestationalObesity

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehaviorPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • reda mokhtar, lecuterer

    Ain Shams University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

aya abdelaziz, postgraduat

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 21, 2021

Study Start

August 1, 2021

Primary Completion

November 1, 2021

Study Completion

December 1, 2021

Last Updated

July 20, 2021

Record last verified: 2021-04